Article: Plasma levels of 7-hydroxymethotrexate after high-dose methotrexate treatment

Thirteen patients with cancer being treated with high-dose methotrexate (MTX) chemotherapy (350-5,000 mg/6 h IV were entered in this study. Plasma levels of MTX and 7-OHMTX, its main circulating metabolite, were measured by an HPLC technique. 7-OHMTX appears rapidly in the blood, reaching a maximum 6-12 h after the beginning of treatment. The elimination of 7-OHMTX is slower than that of MTX, but the elimination half-lives (24-48 h) are not significantly different: 25.2 h for 7-OHMTX versus 20.3 h for MTX. In all cases, 24 h after starting infusion plasma levels of 7-OHMTX exceeded those of MTX. There was a positive and significant correlation between the dose administered and peak plasma 7-OHMTX. Finally, 7-OHMTX formation was shown to be relatively stable throughout the treatment.

Citing Articles

Kinetics of 7-hydroxy-methotrexate after high-dose methotrexate therapy.

Erttmann R, Bielack S, LANDBECK G Cancer Chemother Pharmacol. 1985; 15(2):101-4.

PMID: 3874719 DOI: 10.1007/BF00257517.

Renal excretion and pharmacokinetics of methotrexate and 7-hydroxy-methotrexate following a 24-h high dose infusion of methotrexate in children.

Winograd B, Lippens R, Oosterbaan M, Dirks M, Vree T, van der Kleijn E Eur J Clin Pharmacol. 1986; 30(2):231-8.

PMID: 3709652 DOI: 10.1007/BF00614310.

Pharmacokinetics of anticancer drugs in children.

Crom W, Rodman J, Teresi M, Kavanagh R, Christensen M, Relling M Clin Pharmacokinet. 1987; 12(3):168-213.

PMID: 3555940 DOI: 10.2165/00003088-198712030-00002.

7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia.

Borsi J, Sagen E, Romslo I, Slordal L, MOE P Cancer Chemother Pharmacol. 1990; 27(2):164-7.

PMID: 2249335 DOI: 10.1007/BF00689104.

References

1.

Witte A, Whitehead V, Rosenblatt D, Vuchich M . Synthesis of methotrexate polyglutamates by bone marrow cells from patients with leukemia and lymphoma. Dev Pharmacol Ther. 1980; 1(1):40-6. View

2.

Jacobs S, Stoller R, Chabner B, Johns D . 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate. J Clin Invest. 1976; 57(2):534-8. PMC: 436681. DOI: 10.1172/JCI108308. View

3.

Shen D, AZARNOFF D . Clinical pharmacokinetics of methotrexate. Clin Pharmacokinet. 1978; 3(1):1-13. DOI: 10.2165/00003088-197803010-00001. View

4.

Nelson J, Harris B, DECKER W, Farquhar D . Analysis of methotrexate in human plasma by high-pressure liquid chromatography with fluorescence detection. Cancer Res. 1977; 37(11):3970-3. View

5.

Christophidis N, Louis W, Lucas I, Moon W, Vajda F . Renal clearance of methotrexate in man during high-dose oral and intravenous infusion therapy. Cancer Chemother Pharmacol. 1981; 6(1):59-64. DOI: 10.1007/BF00253011. View

6.

Lankelma J, van der Klein E, Ramaekers F . The role of 7-hydroxymethotrexate during methotrexate anti-cancer therapy. Cancer Lett. 1980; 9(2):133-42. DOI: 10.1016/0304-3835(80)90117-2. View

7.

Chan K, Nayar M, Cohen J, Chlebowski R, Liebman H, STOLINSKY D . Metabolism of methotrexate in man after high and conventional doses. Res Commun Chem Pathol Pharmacol. 1980; 28(3):551-61. View

8.

Rosenblatt D, Whitehead V, Dupont M, Vuchich M, Vera N . Synthesis of methotrexate polyglutamates in cultured human cells. Mol Pharmacol. 1978; 14(1):210-4. View

9.

Chabner B, Donehower R, Schilsky R . Clinical pharmacology of methotrexate. Cancer Treat Rep. 1981; 65 Suppl 1:51-4. View

10.

Schilsky R, Bailey B, Chabner B . Methotrexate polyglutamate synthesis by cultured human breast cancer cells. Proc Natl Acad Sci U S A. 1980; 77(5):2919-22. PMC: 349517. DOI: 10.1073/pnas.77.5.2919. View

11.

Breithaupt H, Kuenzlen E . Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate. Cancer Treat Rep. 1982; 66(9):1733-41. View

12.

Monjanel S, Rigault J, Cano J, Carcassonne Y, Favre R . High-dose methotrexate: preliminary evaluation of a pharmacokinetic approach. Cancer Chemother Pharmacol. 1979; 3(3):189-96. DOI: 10.1007/BF00262421. View

Plasma Levels of 7-hydroxymethotrexate After High-dose Methotrexate Treatment